Files

Download

Download Full Text (480 KB)

Date

2019

Abstract

As the popularity of cannabidiol (CBD) increases, more patients are interested in trying a "natural" adjunct to more standard medications. But with no current FDA oversight, an estimated 70% of CBD products could be mislabeled. In Vermont, federal regulation requires hemp products to contain less than 0.3% THC, but this has only been tested one time at one location since the 2018 Farm Bill was passed. The goal of this project was to address common questions, recommend specific dosing, identify what to look for when purchasing, and list local and online resources for patients about CBD. An educational handout and a "smartphrase" were created to address these concerns.

Clinical Site

UVMMC Family Medicine Hinesburg

Keywords

CBD, cannabidiol, THC, patient education, Vermont

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Disciplines

Alternative and Complementary Medicine | Medical Education | Primary Care

Educating Patients on Cannabidiol (CBD)

Share

COinS